NPI: 1588193544 · INDIANAPOLIS, IN 46202 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 06/05/2017
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 06/05/2017 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 47,667 | $155K |
| 2019 | 30,687 | $195K |
| 2020 | 34,205 | $256K |
| 2021 | 17,916 | $370K |
| 2022 | 22,876 | $569K |
| 2023 | 7,761 | $487K |
| 2024 | 3,280 | $266K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 65,290 | 3,864 | $2.14M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 47,789 | 1,704 | $103K |
| J1756 | Injection, iron sucrose, 1 mg | 9,729 | 1,665 | $30K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 175 | 63 | $17K |
| J1270 | Injection, doxercalciferol, 1 mcg | 30,322 | 1,804 | $11K |
| 83970 | 1,325 | 842 | $500.88 | |
| A4657 | Syringe, with or without needle, each | 2,889 | 1,631 | $148.98 |
| 82728 | 793 | 507 | $102.47 | |
| 83550 | 806 | 515 | $69.24 | |
| 85041 | 1,832 | 1,316 | $69.02 | |
| 85048 | 1,825 | 1,311 | $61.76 | |
| 83540 | 880 | 555 | $58.62 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 184 | 128 | $45.07 |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 177 | 106 | $41.69 |
| G0008 | Administration of influenza virus vaccine | 51 | 40 | $0.00 |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | 260 | 66 | $0.00 |
| 90674 | 65 | 42 | $0.00 |